Cargando…

A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator

BACKGROUND: The ubiquitin-editing cytosolic enzyme A20, the major negative regulator of toll-like receptor (TLR)-mediated cellular inflammatory responses, has tight genetic linkage with systemic sclerosis (SSc). Because recent studies implicate endogenous ligand-driven TLR signaling in SSc pathogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Swati, Wang, Wenxia, Graham, Lauren Van Duyn, Varga, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048449/
https://www.ncbi.nlm.nih.gov/pubmed/27716397
http://dx.doi.org/10.1186/s13075-016-1118-7
_version_ 1782457592640962560
author Bhattacharyya, Swati
Wang, Wenxia
Graham, Lauren Van Duyn
Varga, John
author_facet Bhattacharyya, Swati
Wang, Wenxia
Graham, Lauren Van Duyn
Varga, John
author_sort Bhattacharyya, Swati
collection PubMed
description BACKGROUND: The ubiquitin-editing cytosolic enzyme A20, the major negative regulator of toll-like receptor (TLR)-mediated cellular inflammatory responses, has tight genetic linkage with systemic sclerosis (SSc). Because recent studies implicate endogenous ligand-driven TLR signaling in SSc pathogenesis, we sought to investigate the regulation, role and mechanism of action of A20 in skin fibroblasts. METHOD: A20 expression and the effects of forced A20 expression or siRNA-mediated A20 knockdown on fibrotic responses induced by transforming growth factor-ß (TGF-ß) were evaluated was evaluated in explanted human skin fibroblasts. Additionally, A20 regulation by TGF-ß, and by adiponectin, a pleiotropic adipokine with anti-fibrotic activity, was evaluated. RESULTS: In normal fibroblasts, TGF-ß induced sustained downregulation of A20, and abrogated its TLR4-dependent induction. Forced expression of A20 aborted the stimulation of collagen gene expression and myofibroblast transformation induced by TGF-ß, and disrupted canonical Smad signaling and Smad-dependent transcriptional responses. Conversely, siRNA-mediated knockdown of A20 enhanced the amplitude of fibrotic responses elicited by TGF-ß. Adiponectin, previously shown to block TLR-dependent fibrotic responses, elicited rapid and sustained increase in A20 accumulation in fibroblasts. CONCLUSION: These results identify the ubiquitin-editing enzyme A20 as a novel endogenous mechanism for negative regulation of fibrotic response intensity. Systemic sclerosis-associated genetic variants of A20 that cause impaired A20 expression or function, combined with direct suppression of A20 by TGF-ß within the fibrotic milieu, might play a significant functional role in persistence of fibrotic responses, while pharmacological augmentation of A20 inhibitory pathway activity might represent a novel therapeutic strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-1118-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5048449
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50484492016-10-11 A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator Bhattacharyya, Swati Wang, Wenxia Graham, Lauren Van Duyn Varga, John Arthritis Res Ther Research Article BACKGROUND: The ubiquitin-editing cytosolic enzyme A20, the major negative regulator of toll-like receptor (TLR)-mediated cellular inflammatory responses, has tight genetic linkage with systemic sclerosis (SSc). Because recent studies implicate endogenous ligand-driven TLR signaling in SSc pathogenesis, we sought to investigate the regulation, role and mechanism of action of A20 in skin fibroblasts. METHOD: A20 expression and the effects of forced A20 expression or siRNA-mediated A20 knockdown on fibrotic responses induced by transforming growth factor-ß (TGF-ß) were evaluated was evaluated in explanted human skin fibroblasts. Additionally, A20 regulation by TGF-ß, and by adiponectin, a pleiotropic adipokine with anti-fibrotic activity, was evaluated. RESULTS: In normal fibroblasts, TGF-ß induced sustained downregulation of A20, and abrogated its TLR4-dependent induction. Forced expression of A20 aborted the stimulation of collagen gene expression and myofibroblast transformation induced by TGF-ß, and disrupted canonical Smad signaling and Smad-dependent transcriptional responses. Conversely, siRNA-mediated knockdown of A20 enhanced the amplitude of fibrotic responses elicited by TGF-ß. Adiponectin, previously shown to block TLR-dependent fibrotic responses, elicited rapid and sustained increase in A20 accumulation in fibroblasts. CONCLUSION: These results identify the ubiquitin-editing enzyme A20 as a novel endogenous mechanism for negative regulation of fibrotic response intensity. Systemic sclerosis-associated genetic variants of A20 that cause impaired A20 expression or function, combined with direct suppression of A20 by TGF-ß within the fibrotic milieu, might play a significant functional role in persistence of fibrotic responses, while pharmacological augmentation of A20 inhibitory pathway activity might represent a novel therapeutic strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-1118-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-03 2016 /pmc/articles/PMC5048449/ /pubmed/27716397 http://dx.doi.org/10.1186/s13075-016-1118-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bhattacharyya, Swati
Wang, Wenxia
Graham, Lauren Van Duyn
Varga, John
A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
title A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
title_full A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
title_fullStr A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
title_full_unstemmed A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
title_short A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
title_sort a20 suppresses canonical smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048449/
https://www.ncbi.nlm.nih.gov/pubmed/27716397
http://dx.doi.org/10.1186/s13075-016-1118-7
work_keys_str_mv AT bhattacharyyaswati a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator
AT wangwenxia a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator
AT grahamlaurenvanduyn a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator
AT vargajohn a20suppressescanonicalsmaddependentfibroblastactivationnovelfunctionforanendogenousinflammatorymodulator